Entero Therapeutics (Nasdaq: ENTO) Employee Directory

Entero Therapeutics (Nasdaq: ENTO) Global Highlights

Location

Employees

North America

7

• United States Of America
  6
• Canada
  1

Asia

1

• India
  1

Europe

1

• France
  1

North America accounts for 78% of Entero Therapeutics (Nasdaq: ENTO)'s workforce, followed by Asia (11%) and Europe (11%).

Entero Therapeutics (Nasdaq: ENTO)'s Leadership

• 
  A. S.

  Chief Financial Officer

  Mobile Phone

  Email
• 
  Y. L.

  Directeur R&D Pharma

  Mobile Phone

  Email

Entero Therapeutics (Nasdaq: ENTO) Employee Metrics

• Business
• Entrepreneurship
• Biotechnology
• Human Resources
• Other
• Quality Assurance

Biotechnology is the largest department at 33% of profiles with a known department, followed by Business (33%) and Quality Assurance (33%).

Contact profiles from Entero Therapeutics (Nasdaq: ENTO)

• 
  A. S.

  Chief Financial Officer

  Mobile Phone

  Email

  Canada

  Oct 28, 2025
• 
  Y. L.

  Directeur R&D Pharma

  Mobile Phone

  Email

  France, Provence-Alpes-Cote D'Azur

  Feb 26, 2024

• 1

Frequently Asked Questions

What are the largest departments at Entero Therapeutics (Nasdaq: ENTO)?

Biotechnology is the largest department at 33% of profiles with a known department, followed by Business (33%) and Quality Assurance (33%).

Where are Entero Therapeutics (Nasdaq: ENTO)'s employees located?

Entero Therapeutics (Nasdaq: ENTO) has about 5 employees across 3 continents, most of them in North America. North America accounts for 78% of Entero Therapeutics (Nasdaq: ENTO)'s workforce, followed by Asia (11%) and Europe (11%). By country, the largest groups are United States Of America (67%), Canada (11%) and India (11%).

How many employees does Entero Therapeutics (Nasdaq: ENTO) have currently?

Entero Therapeutics (Nasdaq: ENTO) has approximately 5 employees as of October 2026. These team members are located across 3 continents, including North America, Asia and Europe.

Who are Entero Therapeutics (Nasdaq: ENTO)'s key employees and leadership?

As of October 2026, Entero Therapeutics (Nasdaq: ENTO)'s key employees include:

• Chief Financial Officer: A. S.
• Directeur R&D Pharma: Y. L.

Looking for contact data? Unlock accurate emails and phone numbers for your ideal prospects with LeadIQ.

What is Entero Therapeutics (Nasdaq: ENTO)'s most common email format?

Entero Therapeutics (Nasdaq: ENTO) employees' email format typically follows the pattern of FLast@azurrx.com. Trying to find reliable and up-to-date employee contact data? Find more Entero Therapeutics (Nasdaq: ENTO) email formats with LeadIQ.

What is Entero Therapeutics (Nasdaq: ENTO) known for?

Entero Therapeutics (Nasdaq: ENTO) was founded in 2014 and operates in the Pharmaceutical Manufacturing industry. You can contact Entero Therapeutics (Nasdaq: ENTO)'s main corporate office by phone at

+1-646-699-****

. Explore Entero Therapeutics (Nasdaq: ENTO)'s company overview page for more information.